Phibro Animal Health (PAHC) Cash from Financing Activities (2013 - 2026)

Phibro Animal Health's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$2.3 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 92.86% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at -$12.7 million (down 105.87% YoY), while the FY2025 annual figure was $207.1 million, up 3160.49% from the prior year.
• Cash from Financing Activities was -$2.3 million for Q1 2026 at Phibro Animal Health, up from -$19.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $276.3 million in Q4 2024 to a low of -$32.2 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged $14.4 million across 5 years, with a median of $1.3 million in 2023.
• Biggest YoY gain for Cash from Financing Activities was 1979.09% in 2024; the steepest drop was 2352.85% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at $3.7 million in 2022, then slumped by 495.72% to -$14.7 million in 2023, then surged by 1979.09% to $276.3 million in 2024, then plunged by 106.87% to -$19.0 million in 2025, then surged by 87.88% to -$2.3 million in 2026.
• The last three Cash from Financing Activities figures came in at -$2.3 million (Q1 2026), -$19.0 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.